Drugs that contain Telaprevir

1. List of Incivek drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7820671 VERTEX PHARMS Peptidomimetic protease inhibitors
Feb, 2025

(1 year, 11 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8431615 VERTEX PHARMS Dose forms
May, 2028

(5 years from now)

Market Authorisation Date: 23 May, 2011

Treatment: Method of treating chronic hepatitis c

Dosage: TABLET;ORAL

More Information on Dosage

INCIVEK family patents

15

United States

12

Korea, Republic of

11

European Union

9

China

8

Taiwan, Province of China

6

Japan

5

Norway

4

Germany

4

Spain

3

Hong Kong

3

Canada

3

Israel

3

Australia

2

New Zealand

2

Mexico

2

Austria

2

EA

2

Ukraine

2

Ecuador

2

Denmark

1

Portugal

1

El Salvador

1

Malaysia

1

Russia

1

Brazil

1

Croatia

1

Argentina

1

Peru

1

South Africa

1

Slovakia

1

Cyprus

1

Hungary

1

Slovenia

1

Luxembourg

1

Czech Republic

1

Poland

1

Chile

1

Algeria

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic